Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Enzo Life Sciences Ceramide monoclonal antibody (MID 15B4) (50 tests)
SDP

Supplier:  Enzo Life Sciences ALX804196T050

Encompass_Preferred

Clone: MID 15B4. Host: Mouse. Isotype: IgM. Immunogen: Ceramide (sphingosine-[trans-D-erythro-2-amino-4-octadecene-1,3-diol]) conjugated to BSA. Source: Purified from ascites by gel filtration on sephacryl S-300. Species Reactivity: Species independent. Specificity: Recognizes C16- and C24-ceramide, dihydroceramide, sphingomyelin and phosphatidylcholine in highly artificial lipid overlay test systems. Under more physiological in vitro and in vivo conditions highly specific for ceramide and does not cross-react with sphingomyelin, cholesterol or other phospholipids. Applications: ELISA. Flow Cytometry, ICC, IHC (PS). Recommended dilutions: ELISA (1:10). Immunohistochemistry (1:10). Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. Formulation: Liquid. In PBS, pH 7.2, containing 0.5M sodium chloride, 0.1% BSA and 0.09% sodium azide.

Catalog No. NC9970569


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.